Pfizer Provides Update on Ownership Interest in Haleon
Jun 1, 2022 · However, in keeping with Pfizer’s transformation into a more focused, global leader in science-based innovative medicines and vaccines, the company intends to exit its 32% ownership interest in Haleon in a disciplined manner, with the objective of maximizing value for Pfizer shareholders.
Pfizer Sells $700M Stake in Haleon, Trimming Ownership to 7.3%
Jan 16, 2025 · Once complete, Pfizer's stake in Haleon will fall from 15.0% to around 7.3%. Pfizer's move comes after Haleon's spin-off as an independent consumer healthcare company, part of plans to reshape its ...
Pfizer Sells $3.26B Stake in Haleon - Nasdaq
Oct 1, 2024 · Pfizer Inc. (PFE) has sold its stake worth $3.26 billion in UK-based consumer healthcare company Haleon PLC (GB:HLN). With this transaction, Pfizer’s ownership in Haleon has been reduced to...
Drug giant Pfizer sells $3.3 bln stake in Sensodyne-maker Haleon
Sep 30, 2024 · Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and Advil...
Pfizer Further Pares Haleon Stake With £2.5 Billion Sale - Yahoo …
Jan 15, 2025 · Pfizer sold shares of Haleon last year, including a £2.4 billion overnight sale in the autumn. Haleon was formed in 2022 from a combination of GSK Plc and Pfizer’s consumer-health units.
Pfizer offloads $3.5 bln stake in Sensodyne-maker Haleon
Mar 19, 2024 · Haleon said on Tuesday top shareholder Pfizer offloaded a roughly $3.5 billion stake in the consumer healthcare firm, bringing down its holding in the British company to 22.6%.
Pfizer to cut stake in Sensodyne toothpaste-maker Haleon to 24%
Mar 18, 2024 · Consumer healthcare firm Haleon said on Monday that U.S. drugmaker Pfizer , its top shareholder, will sell down its stake in the company to about 24%.
Drug Giant Pfizer Sells $3.3 Billion Stake in Sensodyne-Maker Haleon
Sep 30, 2024 · (Reuters) -Pfizer sold a stake in British consumer healthcare group Haleon worth about $3.26 billion on Monday, cutting its shareholding in the maker of Sensodyne toothpaste and Panadol and...
Pfizer to sell $3 billion stake in Sensodyne maker Haleon
Jan 15, 2025 · (Reuters) -Pfizer will sell shares worth 2.50 billion pounds ($3.05 billion) in Haleon, lowering its stake in the British consumer healthcare company to about 7.3% from 15%, its bookrunner...
Following the demerger and listing of Haleon on the London Stock Exchange (LSE), which is expected to occur in July 2022, Pfizer will continue to hold a 32% ownership interest in Haleon.